DarioHealth (DRIO) Scheduled to Post Earnings on Wednesday

DarioHealth (NASDAQ:DRIO) will be announcing its earnings results before the market opens on Wednesday, May 15th. Analysts expect the company to announce earnings of ($0.59) per share for the quarter.

DarioHealth (NASDAQ:DRIO) last posted its earnings results on Thursday, March 28th. The company reported ($0.41) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.54) by $0.13. The business had revenue of $3.62 million for the quarter, compared to analyst estimates of $3.57 million. DarioHealth had a negative net margin of 165.96% and a negative return on equity of 48.84%. On average, analysts expect DarioHealth to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

DarioHealth Stock Performance

NASDAQ DRIO opened at $1.61 on Wednesday. The stock has a market capitalization of $47.77 million, a price-to-earnings ratio of -1.58 and a beta of 1.64. The stock has a 50-day moving average of $1.50 and a 200 day moving average of $1.64. The company has a current ratio of 3.79, a quick ratio of 3.38 and a debt-to-equity ratio of 0.42. DarioHealth has a twelve month low of $0.68 and a twelve month high of $4.58.

Analyst Upgrades and Downgrades

Separately, Stifel Nicolaus reiterated a “buy” rating and issued a $4.00 price objective on shares of DarioHealth in a report on Monday, April 1st.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.